Long-Term Nicotine Treatment of Mild Cognitive Impairment — Paul S. Aisen (VANDERBILT UNIVERSITY MEDICAL CENTER)
Precursor conditions to Alzheimer’s disease (AD) such as Mild Cognitive Impairment (MCI) are now a target of patient identification and potential treatment, as studies clearly showing that the risk of
| Project title | Long-Term Nicotine Treatment of Mild Cognitive Impairment |
|---|---|
| Project number | 2R56AG047992-07A1 |
| PI name | Paul S. Aisen |
| Institution | VANDERBILT UNIVERSITY MEDICAL CENTER |
| Funding mechanism | R56 |
| Agency | NIA |
| Award amount | $6.09M |
| Fiscal year | 2022 |
| Project start | 2015-09-15T00:00:00 |
| Project end | 2026-01-31T00:00:00 |
| Abstract | Precursor conditions to Alzheimer’s disease (AD) such as Mild Cognitive Impairment (MCI) are now a target of patient identification and potential treatment, as studies clearly showing that the risk of |
| Key terms | <ACh Receptors><AD dementia><AD pathology><Acetylcholine><Acetylcholine Receptors><Activities of Dai |
$799/mo
Try GrantRadar →